Amyloid in Alzheimer's disease and prion-related encephalopathies: Studies with synthetic peptides

Progress in Neurobiology

Volumn 49, Issue 4, 1996, Pages 287-315

  Forloni, Gianluigi ^a   Tagliavini, Fabrizio ^b   Bugiani, Orso ^b   Salmona, Mario ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; PEPTIDE;

ALZHEIMER DISEASE; BRAIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRION; PRIORITY JOURNAL; REVIEW;

EID: 0030198517     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(96)00013-5     Document Type: Review

References (285)

1. Abe, E., Casamenti, F., Giovanelli, L., Scali, C. and Pepeu, G. (1994) Administration of amyloid β-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res. 636, 162-164.
2. Abraham, C. A., Selkoe, D. J. and Potter, H. (1988) Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52, 487-501.
3. Abraham, C. R., Shirahama, T. and Potter, H. (1990) The protease inhibitor α1-antichymotrypsin is associated solely with amyloid deposits containing the β-protein and is localized in specific cells of both normal and diseased brain. Neurobiol. Aging 11, 123-129.
4. Allsopp, T. E., Wyatt, S., Paterson, H. F. and Davies, A. M. (1993) The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73, 295-307.
5. Alzheimer, A. (1907) Über eine eigenartige Erkrankung der Hirnrinde. Zertralbl. Nervenhilk. Psychiatr. 18, 177-179.
6. Anderson, K., Launer, L. J., Ott, A., Hoes, A. W., Breteler, M. M. B. and Hofman, A. (1995) Do non-steroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease. Neurology 45, 1441-1445.
7. Araujo, D. M. and Cotman, C. (1992) β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res. 569, 141-145.
8. Arispe, N., Pollard, H. B. and Rojas, E. (1993a) Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein (A beta P-(1-40)) in bilayer membranes. Proc. Natl Acad. Sci. USA 90, 10573-10577.
9. Arispe, N., Rojad, E. and Pollard, H. B. (1993b) Alzheimer's disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminium. Proc. Natl Acad. Sci. USA 90, 567-571.
10. Barrow, C. and Zagorski, M. (1991) Solution structures of peptide and its constituent fragments: relation to amyloid deposition. Science 353, 179-182.
11. Barrow, C., Yasuda, A., Kenny, P. and Zagorski, M. (1992) Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. J. Mol. Biol. 225, 1075-1093.
12. Basler, K., Oesch, B., Scott, M., Westaway, D., Wälchli, M., Groth, D. F., McKinley, M. P., Prusiner, S. B. and Weissmann, C. (1986) Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46, 417-428.
13. Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, P. and Berger, M. (1992) Interleukin-6 and α2-microglobulin indicate an acute-phase state in Alzheimer's disease. FEBS Lett. 285, 111-114.
14. Behl, C., Davis, J., Cole, M. G. and Schubert, D. (1992) Vitamin E protects nerve cells from amyloid β protein toxicity, Biochem. Biophys. Res. Commun. 186, 944-950.
15. Behl, C., Davis, J. B., Lesley, R. and Schubert, D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
16. Bellinger-Kawahara, C., Diener, T. O., McKinley, M. P., Groth, D. F., Smith, D. R. and Prusiner, S. B. (1987) Purified scrapie resist inactivation by UV irradiation. J. Virol. 61, 159-166.
17. Benzing, W. C., Mufson, E. J. and Armstrong, D. M. (1993) Alzheimer's disease-like dystrophic neurites characteristically associated with senile plaques are not found within other neurodegenerative diseases unless amyloid-β-protein deposition is present. Brain Res. 606, 10-18.
18. Bessen, R. A., Kocisko, D. A., Raymond, G. J., Nandan, S., Lansbury, P. and Caughey, B. (1995) Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375, 698-700.
19. Blessed, G., Tomlinson, B. E. and Roth, M. (1968) The association between quantitative measures of dementia and senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiat. 114, 797-811.
20. Bolton, D. C., McKinley, M. and Prusiner, S. B. (1982) Identification of a protein that purifies with the scrapie prion. Science 218, 1309-1311.
21. Breitner, J. C., Gau, B. A., Welsh, K. A., Plassman, B. L., McDonald, W. M., Helms, M. J. and Anthony, J. C. (1994) Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 44, 227-232.
22. Brookes, A. J. and St Clair, D. (1994) Synuclein proteins and Alzheimer's disease. Trends Neurosci. 17, 404-405.
23. Brorson, J. R., Bindokas, V. P., Iwama, T., Marcuccilli, C. J., Chisholm, J. C. and Miller, R. J. (1995) The Ca2 + influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation. J. Neurobiol. 26, 325-338.
24. Brown, D. R., Herms, J. and Kretzschmar, H. A. (1994) Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment. NeuroReport 5, 2057-2060.
25. Bugiani, O., Giaccone, G., Frigerio, L., Farlow, M. R., Ghetti, B. and Tagliavini, F. (1994) Apolipoprotein E and J immunoreactivity in Gerstmann-Sträussler-Scheinker. Neurobiol. Aging 15, S156.
26. Bugiani, O., Diomede, L., Algeri, M., De Gioia, L., Florio, T., Schettini, G., Tagliavini, F., Forloni, G. and Salmona, M. (1995) A prion protein fragment modifies plasma membrane viscosity and intracellular calcium level (abs). J. Neuropathol. Exp. Neurol. 54, 449.
27. Busciglio, J., Lorenzo, A. and Yankner, B. A. (1992) Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging 13, 609-612.
28. Busciglio, J., Yeh, J. and Yankner, B. A. (1993) beta-Amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J. Neurochem. 61, 1565-1568.
29. Busciglio, J., Lorenzo, A., Yeh, J. and Yankner, B. A. (1995) β-Amyloid fibrils induce Tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888.
30. Bush, A. I., Pettingell, W. H., Multhaup, G., Paradis, M. D., Vonsattel, J.-P., Gusella, J. F., Beyreuther, K., Masters, C. L. and Tanzi, R. E. (1994) Rapid induction of Alzheimer Ab amyloid formation by Zinc. Science 265, 1464-1467.
31. Buttke, T. M. and Sandstrom, P. A. (1994) Oxidative stress as a mediator of apoptosis. Immunol. Today 15, 7-10.
32. Buxbaum, J. D., Oishi, M. and Chen, H. I. (1992) Cholinergic agonists and interleukin-1 processing and secretion of the Alzheimer b/A4 amyloid protein precursor. Proc. Natl Acad. Sci. USA 89, 10075-10078.
33. Büeler, H., Aguzzi, A., Sailer, A., Aguet, M. and Weissmann, C. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347.
34. Cafe, C., Torri, C., Bertorelli, L., Angeretti, N., Lucca, E., Forloni, G. and Marzatico, F. (1996) Oxidative stress after acute and chronic application of amyloid fragment 25-35 in cortical cultures. Neurosci. Lett. 203, 1-5.
35. Camilleri, P., Haskins, N. J. and Howlett, D. R. (1994) β-Cyclodextrin interacts with Alzheimer amyloid β-A4 peptide. FEBS Lett. 341, 256-258.
36. Caporaso, G. L., Gandy, S. E., Buxbaum, J. D., Ramabhadran, T. V. and Greengard, P. (1992) Protein phosphorylation regulates secretion of Alzheimer's bA4 amyloid precursor protein. Proc. Natl Acad. Sci. USA 89, 3055-3059.
37. Caputo, C. B., Sobel, I. R., Sygowski, L. A., Lampe, R. A. and Spreen, R. C. (1993) The influence of amino acid sequence on the fibrillogenicity and amyloidogenicity of the carboxy-terminus of beta-amyloid precursor protein. Arch. Biochem. Biophys. 306, 321-330.
38. Carrette, B., Poulian, P. and Delacourte, A. (1993) Electrophysiological effects of 25-35 amyloid β-protein on guinea-pig lateral septal neurons. Neurosci. Lett. 151, 111-114.
39. Castaño, E., Ghiso, J., Prelli, F. P., Gorevic, P. D., Migheli, A. and Frangione, B. (1986) In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease β-protein. Biochem. Biophys. Res. Commun. 141, 782-789.
40. Caughey, B., Neary, K. and Buller, R. et al.. (1990) Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells. J. Virol. 64, 1093-1101.
41. Caughey, B. and Raymond, J. (1991) The scrapie-associated form of PrP is made from a cell surface precursor that is both protease-and phospholipase-sensitive. J. Biol. Chem. 266, 18217-18223.
42. Caughey, B. and Race, R. E. (1992) Potent inhibition of scrapie-associated PrP accumulation by Congo red. J. Neurochem. 59, 768-771.
43. Checler, F. (1995) Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65, 1431-1444.
44. Chen, S. G., Teplow, D. B., Parchi, P., Teller, J. K., Gambetti, P. and Autilio-Gambetti, L. (1995) Truncated forms of the human prion protein in normal brain and prion diseases. J. Biol. Chem. 279, 19173-19180.
45. Chiesa, R., Angeretti, N., Lucca, E., Salmona, M., Tagliavini, F., Bugiani, O. and Forloni, G. (1996) Clusterin (SGP-2) induction in rat astroglial cells exposed to prion protein fragment 106-126. Eur. J. Neurosci. 8, 589-597.
46. Citron, M., Vigo-Pelfrey, C., Teplow, D. B., Miller, C., Schenk, D., Johnston, J., Winblad, B., Venizelos, N., Lannfelt, L. and Selkoe, D. (1994) Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl Acad. Sci. USA 91, 11993-11997.
47. Citron, M., Oltersdolf, T., Haass, C., Mcconglogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I. and Selkoe, D. (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer's disease causes increased β-protein production. Nature 360, 672-674.
48. Cleary, J., Hittner, J. M., Semotuk, M., Mantyh, P. and O'Hare, E. (1995) Beta-amyloid (1-40) effects on behavior and memory. Brain Res. 682, 69-74.
49. 21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid β/A4 peptide. Neurosci. Lett. 161, 17-20.
50. Come, J. H., Fraser, P. E. and Lansbury, P. T. (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl Acad. Sci. USA 90, 5959-5963.
51. Copani, A., Koh, J. Y. and Cotman, C. W. (1991) β-Amyloid increases neuronal susceptibility to injury by glucose deprivation. NeuroReport 2, 763-765.
52. Copani, A., Bruno, V., Battaglia, G., Leanza, G., Pellitteri, R., Russo, A., Stanzani, S. and Nicoletti, F. (1995) Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by β-amyloid peptide. Mol. Pharmacol. 47, 890-897.
53. Coria, F., Moreno, A., Rubio, I., Garcia, M. A., Morato, E. and Mayor, F. Jr. (1993) The cellular pathology associated with Alzheimer beta-amyloid deposits in non-demented aged individuals. Neuropathol. Appl. Neurobiol. 19, 261-268.
54. Cotman, C. W. and Anderson, A. J. (1995) A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10, 19-45.
55. Cuillè, J. and Chelle, P. L. (1939) Experimental transmission of trembling to the goat. C.r. Sc. Acad. Sci 208, 1058-1060.
56. David-Salinas, J. and Van Nostrand, W. E. (1995) Amyloid β protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J. Biol. Chem. 270, 20887-20890.
57. David-Salinas, J., Saporito-Irwin, S. M., Cotman, C. W. and Van Nostrand, W. E. (1995) Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65, 931-934.
58. De Armond, S. J. and Prusiner, S. B. (1995) Etiology and pathogenesis of prion diseases. Am. J. Pathol. 146, 785-811.
59. De Armond, S. J., Mobley, W. C., DeMott, D. L., Barry, R. A. and Beckstead, J. H. (1987) Changes in the localization of brain prion proteins during scrapie infection. Neurology 37, 1271-1280.
60. De Gioia, L., Selvaggini, C., Ghibaudi, E., Diomede, L., Bugiani, O., Forloni, G., Tagliavini, F. and Salmona, M. (1994) Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. J. Biol. Chem. 269, 7859-7862.
61. DeKosky, S. T., Harbourg, R. E. and Schmitt, F. A. et al.. (1991) Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological and cognitive correlations. Ann. Neurol. 32, 625-632.
62. Del Bo, R., Angeretti, N., Lucca, E., De Simoni, G. and Forloni, G. (1995) Reciprocal control of inflammatory cytokines, IL-1 and IL-6 and β-amyloid production in cultures. Neurosci. Lett. 188, 70-74.
63. Donate, R. (1991) Perspectives in S-100 protein biology. Cell Calcium 12, 713-726.
64. Dornan, W. A., Kang, D. E., McCampbell, A. and Kang, E. E. (1993) Bilateral injections of beta A(25-35) + IBO into the hippocampus disrupts acquisition of spatial learning in the rat. NeuroReport 5, 165-168.
65. Dragunow, M., Faull, R. L. M., Lawlor, P., Beilharz, E. J., Singleton, K., Walker, E. B. and Mee, E. (1995) In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. NeuroReport 6, 1053-1057.
66. Eckert, A., Hartmann, H. and Muller, W. E. (1993) β-Amyloid protein enhances the mitogen-induced calcium response in circulating human lymphocytes. FEBS Lett. 330, 49-52.
67. Edwards, S. N., Buckmaster, A. E. and Tolkovsky, A. M. (1991) The death programmed in cultured sympathetic neurons can be suppressed at the post-translational level by nerve growth factor, cyclic AMP and depolarization. J. Neurochem. 57, 2140-2143.
68. Emre, M., Geula, C., Ransil, B. and Mesulam, M. M. (1992) The acute neurotoxicity end effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain. Neurobiol. Aging 13, 553-559.
69. Estus, S., Golde, T. E. and Kunishita, T. et al.. (1992) Potentially amyloidogenic carboxy-terminal derivatives of the amyloid protein precursor. Science 255, 726-728.
70. Evans, K. C., Berger, E. P., Cho, C.-G., Weisgraber, K. H. and Lansbury, P. T. Jr. (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl Acad. Sci. USA 92, 763-767.
71. Fairbain, D. W., Carnahan, K. G., Thwaits, R. N., Grigsby, R. V., Reed Holyoak, G. and O'Neill, K. L. (1995) Detection of apoptosis induced DNA cleavage in scrapie-infected sheep brain. FEMS Microbiol. Lett. 115, 341-346.
72. Fanò, G., Mariggiò, M. A., Angelella, P., Nicoletti, I., Antonica, A., Fulle, S. and Calissano, P. (1993) The S-100 protein causes an increase of intracellular calcium and death of PC12 cells. Neuroscience 53, 919-925.
73. Farlie, P. G., Dringen, R., Rees, S. M., Kannourakis, G. and Bernard, O. (1995) bcl-2 Transgene expression can protect neurons against development and induced cell death. Proc. Natl Acad. Sci. USA 92, 4397-4401.
74. Fasman, G. D., Perczel, A. and Moore, C. D. (1995) Solubilization of β-amyloid-(1-42)-peptide: reversing the β-sheet conformation induced by aluminium with silicates. Proc. Natl Acad. Sci. USA 92, 369-371.
75. Flood, J. F., Morley, J. E. and Roberts, E. (1991) Amnestic effects in mice of four synthetic peptides homologous to amyloid β protein from patients with Alzheimer disease. Proc. Natl Acad. Sci. USA 88, 3363-3366.
76. Florio, T., Grimaldi, M., Scorziello, A., Salmona, M., Bugiani, O., Tagliavini, F., Forloni, G. and Schettini, G. (1995) The prion protein fragment 106-126 increases intracellular calcium levels through a dihydropyridine-sensitive mechanism and induces cortical type I astrocyte proliferation. Soc. Neurosci. Abstr. 21, 494.
77. Forloni, G. (1993) β-Amyloid neurotoxicity. Funct. Neurol. 8, 211-225.
78. Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O. and Tagliavini, F. (1993a) Neurotoxicity of a prion protein fragment. Nature 362, 543-545.
79. Forloni, G., Chiesa, R., Smiroldo, S., Salmona, M., Tagliavini, F. and Angeretti, N. (1993b) Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25-35. NeuroReport 4, 523-526.
80. Forloni, G., Del Bo, R., Angeretti, N., Smiroldo, S., Gabellini, N. and Vantini, G. (1993c) Nerve growth factor does not influence the expression β amyloid precursor protein mRNA in rat brain: in vivo and in vitro studies. Brain Res. 620, 292-296.
81. Forloni, G., Demicheli, F., Giorgi, S., Bendotti, C. and Angeretti, N. (1992) Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Mol. Brain Res. 16, 128-134.
82. Forloni, G., Del Bo, R., Angeretti, N., Chiesa, R., Smiroldo, S., Doni, R., Ghibaudi, E., Salmona, M., Porro, M., Verga, L., Giaccone, G., Bugiani, O. and Tagliavini, F. (1994) A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy. Eur. J. Neurosci. 6, 1415-1422.
83. Fraser, P. E., Nguyen, J. T., Chin, D. T. and Kirschenr, D. A. (1992) Effects of sulfate ions on Alzheimer b/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions. J. Neurochem. 59, 1531-1540.
84. Frautschy, S. A., Baird, A. and Cole, G. M. (1991) Effects of injected Alzheimer β-amyloid cores in rat brain. Proc. Natl Acad. Sci. USA 88, 8362-8366.
85. Friedreich, N. and Kekule, A. (1859) Zur amyloidfrage. Arch. Pathol. Physiol. Klin. Med. 16, 50-65.
86. Frolich, L. and Riederer, P. (1995) Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment. Arzneimittelforschung. 45, 443-446.
87. Fukuyama, R., Wadhwani, K. C., Galdzicki, Z., Rapaport, S. L. and Ehrenstein, G. (1994) β-Amyloid polypeptide increases calcium-uptake in PC12 cells: a possible mechanism for its cellular toxicity in Alzheimer's disease. Brain Res. 667, 269-272.
88. Gajdusek, D. C. (1988) Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to β-plated configurations. J. Neuroimmunol. 20, 95-110.
89. Gajdusek, D. C., Gibbs, C. J. and Alpers, M. (1966) Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 209, 794-796.
90. Gallo, G., Wisniewski, T., Choi-Miura, N.-H., Ghiso, J. and Frangione, B. (1994) Potential role of apolipoprotein-E in fibrillogenesis. Am. J. Pathol. 145, 526-530.
91. Games, D., Khan, M., Soriano, F. G., Keim, P. S., Davis, D. L., Bryant, K. and Lieberburg, I. (1992) Lack of Alzheimer pathology after β-amyloid protein injections in rat brain. Neurobiol. Aging 13, 569-576.
92. Games, D., Adams, D., Alessandrini, R. and Barbour, R. et al.. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527.
93. Garcia, I., Martinou, I., Tsujimoto, Y. and Martinou, J.-C. (1992) Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 258, 302-307.
94. Gasset, M., Baldwin, M. A., Lloyd, D. H., Gabriel, J.-M., Holtzman, D. M., Cohen, F., Fletterick, R. and Prusiner, S. B. (1992) Predicted α-helical regions of the prion protein when synthesized as peptides form amyloid. Proc. Natl Acad. Sci. USA 89, 10940-10944.
95. Gasset, M., Baldwin, M. A., Fletterick, R. J. and Prusiner, S. B. (1993) Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc. Natl Acad. Sci. USA 90, 1-5.
96. Ghetti, B., Tagliavini, F., Giaccone, G., Bugiani, O., Frangione, B., Farlow, M. R. and Dlouthy, S. R. (1994) Familial Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Mol. Neurobiol. 8, 41-48.
97. Giaccone, G., Pedrotti, B., Migheli, A., Verga, L., Perez, J., Racagni, G., Smith, M. A., Perry, J., De Gioia, L., Selvaggini, C., Salmona, M., Ghiso, J., Frangione, B., Islam, K., Bugiani, O. and Tagliavini, F. (1996) βPP and Tau interaction: a possible link between amyloid and NFT formation. J. Amer. Pathol. 148, 79-87.
98. Gianni, L., Bellotti, V., Gianni, A. M. and Merlini, G. (1995) New drug therapy of amyloidoses: resorption of AL-type deposits with 4′-iodo-4′-deoxydoxorubicin. Blood 86, 855-861.
99. Gibbs, C. J., Gajdusek, D. C., Asher, D. M., Alpers, M. P., Daniel, P. M. and Matthews, W. B. (1968) Creutzfeldt-Jacob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 161, 388-389.
100. Giordano, T., Pan, J. B., Monteggia, L. M., Holzman, T. F., Snyder, S. W., Krafft, G., Ghanbari, H. and Kowall, N. W. (1994) Similarities between beta amyloid peptides 1-40 and 40-1: effects on aggregation, toxicity in vitro, and injection in young and aged rats. Expl Neurol. 125, 175-182.
101. Giovanelli, L., Casamenti, F., Scali, I., Bartolini, L. and Pepeu, G. (1995) Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience 66, 781-792.
102. Gitter, B. D., Cox, L. M., Rydel, R. E. and May, P. C. (1995) Amyloid β peptide potentiates cytokine secretion by interleukin-1β-activated human astrocytoma cells. Proc. Natl Acad. Sci. USA 92, 10738-10741.
103. Glenner, G. G. and Wong, W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
104. Goate, A., Chartie-Harlin, M. C. and Mullan, M. et al.. (1991) Segregation of mis-sense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
105. Goldfarb, L. G., Brown, P., Haltia, M., Ghiso, G. and Frangione, B. (1992) Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeldt-Jakob disease show enhanced in vitro formation of morphologically different amyloid fibrils. Proc. Natl Acad. Sci. USA 90, 4451-4454.
106. Good, T. A. and Murphy, R. M. (1995) Aggregation state-dependent binding of β-amyloid peptide to protein and lipid components of rat cortical homogenates. Biochem. Biophys. Res. Commun. 207, 209-215.
107. Gorevic, P. D., Castaño, E. M., Sarma, R. and Frangione, B. (1987) Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic ≈ ray diffraction pattern. Biochem. Biophys. Res. Commun. 147, 854-862.
108. Greenlund, L. J. S., Deckwerth, T. L. and Johnson, E. M. Jr. (1995) Superoxide dismutase delays neuronal apoptosis: a role of reactive oxygen species in programmed neuronal death. Neuron 14, 303-315.
109. Griffin, W. S. T., Stanley, L. C., Ling, C., White, L., MacLeod, V., Perrot, L. J., White, C. L. and Araoz, C. (1989) Brain interleukin-1 and S-100 immunoreactivity are elevated in Down Syndrome and Alzheimer's disease. Proc. Natl Acad. Sci. USA 86, 7611-7615.
110. Haass, C., Schlossmaker, M. G. and Hung, A. Y. et al.. (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-324.
111. Haass, C. and Selkoe, D. J. (1993) Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 75, 1039-1042.
112. Halverson, K., Fraser, P. E., Kirschner, D. A. and Lansbury, P. T. Jr. (1990) Molecular determinants of amyloid deposition in Alzheimer disease: conformational studies with β-protein fragments. Biochemistry 29, 2639-2644.
113. Han, H., Weinreb, P. H. and Lansbury, P. T. (1995) The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: is NAC a common trigger or target in neurodegenerative disease?. Chem. Biol. 2, 163-169.
114. Hadlow, W. J. (1959) Scrapie and kuru. The Lancet 2, 289-290.
115. Hardy, J. and Higgins, G. A. (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185.
116. Harkany, T., De Jong, G. I., Soòs, K., Penke, B., Luiten, P. G. M. and Gulya, K. (1995a) β-Amyloid (1-42) affects cholinergic but not parvalbumin-containing neurons in the septal complex of the rat. Brain Res. 698, 270-274.
117. Harkany, T., Lengevel, Z., Soòs, K., Penke, B., Luiten, P. G. M. and Gulya, K. (1995b) Cholinotoxic effects of β-amyloid (1-42) peptide on cortical projections of the rat nucleus basalis magnocellularis. Brain Res. 695, 71-75.
118. Harris, D. A., Falls, D. L., Johnson, F. A. and Fischbach, G. D. (1991) A prion-like protein from chicken brain co-purifies with an acetylcholine receptor-inducing activity. Proc. Natl Acad. Sci. USA 88, 7664-7668.
119. Harris, M. E., Carney, J. M., Cole, P. S., Hensley, K., Howard. B. J., Martin, L., Bummer, P., Wang, Y., Pedigo, N. W. Jr. and Butterfield, D. A. (1995) β-amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease. NeuroReport 6, 1875-1879.
120. Hendricks, L., Van Duijin, C, M., Cras, P., Cruts, M., Van Hul, W. and Harkskamp, F. (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β amyloid precursor protein gene. Nature Genet. 1, 218-221.
121. Hensley, K., Carney, J. M., Mattson, M. P., Harris, M. and Butterfield, D. A. (1994) Amyloid β-peptide spin trapping II: evidence for decomposition of the PBN spin adduct. Proc. Natl Acad. Sci. USA 91, 3270-3274.
122. Hensley, K., Aksenova, M., Carney, J. M., Harris, M. and Butterfield, D. A. (1995a) Amyloid beta-peptide spin trapping. I: Peptide enzyme toxicity is related to free radical spin trap reactivity. NeuroReport 6, 489-492.
123. Hensley, K., Aksenova, M., Carney, J. M., Harris, M. and Butterfield, D. A. (1995b) Amyloid beta-peptide spin trapping. II: evidence for decomposition of the PBN spin adduct. NeuroReport 6, 493-496.
124. Hilbich, C., Kisters-Voike, B., Reed, J., Masters, C. and Beyreuther, K. (1991) Aggregation and secondary structure of synthetic amyloid β A4 peptides of Alzheimer's disease. J. Mol. Biol. 218, 149-163.
125. Hilbich, C., Kisters-Voike, B., Reed, J., Masters, C. and Beyreuther, K. (1992) Substitution of hydrophobìc amino acids reduce the amyloidogenicity of Alzheimer's disease bA4 peptides. J. Mol. Biol. 228, 1-14.
126. Hokenbery, D. M., Olivai, Z. N., Yin, X., Milliman, C. L. and Korsmeyer, S. J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
127. Howlett, D. R., Jennings, K. H., Lee, D. C., Clark, M. S., Brown, F., Wetzel, R., Wood, S. J., Camilleri, P. and Roberts, G. W. (1995) Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration 4, 23-32.
128. Hsiao, K. K., Diouthy, S. R., Farlow, M. R., Cass, C., DaCosta, M., Coneally, P. M., Hodes, M. E., Ghetti, B. and Prusiner, S. B. (1992) Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Nature Genet. 1, 66-71.
129. Höke, A., Canning, D. R., Malemud, C. J. and Silver, J. (1994) Regional differences in reactive gliosis induced by substrate-bound β-amyloid. Expl Neurol. 130, 56-66.
130. Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., De Silva, H. A. R., Kittel, A. and Saitoh, T. (1995) The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14, 467-475.
131. Jaffe, A. B., Toran-Allorand, D., Greengard, P. and Gandy, S. E. (1994) Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J. Biol. Chem. 269, 13065-13068.
132. Janciauskiene, S., Garcia de Frutos, P., Carlemam, E., Dahlbäck, B. and Eriksson, S. (1995) Inhibition of Alzheimer β peptide fibril formation by serum amyloid component. J. Biol. Chem. 44, 26041-26044.
133. Jarrett, J. T. and Lansbury, P. T. (1993) Seeding "one dimensional crystallization" of amyloid: pathogenic mechanism in Alzheimer disease and scrapie?. Cell 73, 1055-1058.
134. Jenner, P. (1994) Oxidative damage in neurodegenerative disease. The Lancet 344, 796-798.
135. Johnson, S. A., McNeill, T., Cordell, B. and Finch, C. B. (1990) Relation of neuronal APP 751/APP 695 and neurite plaque density in Alzheimer's disease. Science 248, 854-857.
136. Jorgensen, O. S., Brooksbank, B. W. and Balazs, R. (1990) Neuronal plasticity and astrocytic reaction in Down's syndrome and Alzheimer's disease. J. Neurol. Sci. 98, 63-79.
137. Joseph, R. and Han, E. (1992) Amyloid-β-protein fragment 25-35 causes activation of cytoplasmic calcium in neurons. Biochem. Biophys, Res. Commun. 184, 1441-1447.
138. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, G. M., Masters. C. L. and Crzeschink, K. H. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature 325, 733-736.
139. 695 mRNA is predominantly produced in rat and human brain. Biochem. Biophys. Res. Commun. 166, 1192-1200.
140. Kirschner, D. A., Inouye, H., Duffy, L. K., Sinclair, A., Lind, M. and Selkoe, D. J. (1987) Synthetic peptide homologous to β protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc. Natl Acad. Sci. USA 84, 6953-6957.
141. Kisilevsky, R., Lemieux, L. J., Fraser, P. E., Kong, X., Hultin, P. G. and Szarek, W. A. (1995) Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nature Med. 1, 143-148.
142. Koh, J., Yang, L. L. and Cotman, C. W. (1990) β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxin damage. Brain Res. 533, 315-320.
143. Kowall, N. W., Beal, M., Busciglio, J., Duffy, L. K. and Yankner, B. A. (1991) An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. Proc. Natl Acad. Sci. USA 88, 7247-7251.
144. Kowall, N. W., McKee, A., Yankner, B. and Beal, M. (1992) In vivo neurotoxicity of beta amyloid [β1-40)] and the β (25-35) fragment. Neurobiol. Aging 13, 537-542.
145. Kretzschmar, H. A. (1993) Neuropathology of human prion diseases (spongiform encephalopathies). Dev. Biol. Stand. 80, 71-90.
146. Kuroda, Y. and Kawahara, M. (1994) Aggregation of amyloid beta-protein and its neurotoxicity: enhancement by aluminum and other metals. Tohoku. J. Exp. Med. 174, 263-268.
147. LaFerla, F. M., Tinkle. B. T., Bierberich, C. J., Haudenschild, C. C. and Jay, G. (1995) The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genet. 9, 21-30.
148. Le, W.-D., Colom, L., Xie, W.-J., Smith, G., Alexianu, M. and Appel, S. H. (1995) Cell death induced β-amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading apoptosis. Brain Res. 686, 40-60.
149. Levy, E., Carman, M. D. and Fernandez-Madrid, I. (1990) Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrage Dutch-type. Science 248, 1124-1128.
150. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingeh, W. H., Yu, C., Jondro, P. D., Schmidt, S. D., Wang, K., Crowley, A. C., Fu, Y.-H., Guenette, S. Y., Galas, D., Nemens, E., Wijsman, E. M., Bird, T. D., Schellenberg, G. D. and Tanzi, R. (1995a) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-976.
151. Levy-Lahad, E., Wijsman, E. M., Nemens, E., Anderson, L., Goddard, K. A. B., Weber, J. L., Bird, T. D. and Schellenberg, G. D. (1995b) A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-973.
152. Liao, Y. J., Lebo, R. V., Clawson, G. A. and Smuckler, E. A. (1986) Human prion protein cDNA: molecular cloning, chromosomal mapping and biological implications. Science 233, 364-367.
153. Lockaert, B. P., Benicourt, C., Junien, J.-L. and Privat, A. (1994) Inhibitors of free radical formation fail to attenuate direct β-amyloid peptide-mediated neurotoxicity in rat hippocampal cultures. J. Neurosci. Res. 39, 494-505.
154. Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J. and Cotman, C. W. (1993) Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl Acad. Sci. USA 90, 7951-7955.
155. Lorenzo, A. and Yankner, B. A. (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl Acad. Sci. USA 91, 12243-12247.
156. Lucca, U., Tettamanti, M., Forloni, G. and Spagnoli, A. (1994) Non-steroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease. Biol. Psychiat. 121, 85-88.
157. Ma, J., Yee, A., Brewer, H. B. Jr., Das, S. and Potter, H. (1994) Amyloid-associated proteins a1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372, 92-94.
158. Mark, R. J., Ashford, J. W., Goodman, Y. and Mattson, M. P. (1995a) Anticonvulsants attenuate amyloid beta-peptide neurotoxicity, Ca2 + deregulation, and cytoskeletal pathology. Neurobiol. Aging 16, 187-198.
159. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
160. Martin. D. P., Schimdt, R. E., Di Stefano, P. S., Lowry, O. H., Carter, J. G. and Johnson, E. M. Jr. (1988) Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J. Cell Biol. 106, 829-844.
161. Martin, D. P., Ito, A., Horigome, K., Lampe, P. A. and Johnson, E. M. Jr. (1992) Biochemical characterization of programmed cell death in NGF-deprived sympathetic neurons. J. Neurobiol. 23, 1205-1220.
162. 246) familial Alzheimer's cells. NeuroReport 7, 217-220.
163. Martinez, M., Frank, A. and Hernanz, A. (1993) Relationship of interleukin-1 beta and beta 2-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type. J. Neuroimmunol. 48, 235-240.
164. Martinou, J.-C., Dubois-Dauphin, M., Staple, J. K., Rodriguez, I., Frankowski, H., Missotten, M., Albertini, P., Talobot, D., Catsicas, S., Pietra, C. and Huarte, J. (1994) Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13, 1017-1030.
165. Mattson, M. P. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
166. Mattson, M. P. and Goodman, Y. (1995) Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain. Res. 676, 219-224.
167. Maury, C. and Nurmiaho-Lassila, E.-L. (1992) Creation of amyloid fibrils from mutant Asn 187 gelsolin peptides. Biochem. Biophys. Res. Commun. 183, 227-231.
168. Maury, C. P. J. (1995) Molecular pathogenesis of β-amyloidosis in Alzheimer's disease and other cerebral amyloidoses. Lab. Invest. 72, 4-16.
169. May, P. C., Boggs, L. N. and Fuson, K. S. (1993) Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-beta neurotoxicity. J. Neurochem. 61, 2330-2333.
170. 2+ concentration. Arch. Biochem. 269, 365-371.
171. McGeer, P. L. and Rogers, J. (1992) Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 42, 447-449.
172. Meda, L., Cassatella, M. A. C., Szendrei, G., Otvos Jr, L., Baron, P., Villalba, M., Ferrari, D. and Rossi, F. (1995) Activation of microglial cells by β-amyloid protein and mterferon-γ. Nature 374, 647-650.
173. Merlini, G., Ascari, E., Amboldi, N., Bellotti, V., Arbustini, E., Perfetti, V., Ferrari, M., Zorzoli, I., Marinone, G., Diegoli, M., Trizio, D. and Ballinari, D. (1995) Interaction of the anthracycline 4′-iodo-4′-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc. Natl Acad. Sci. USA 92, 2959-2963.
174. Mori, H., Takio, K., Ogawara, M. and Selkoe, D. (1992) Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J. Biol. Chem. 267, 17082-17086.
175. Morris, J. C., Storandt, M., McKeel, D. W., Rubin, E. H., Price, J. L., Grant, E. A. and Berg, L. (1996) Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 46, 707-719.
176. Murdoch, A. D. and Iozzo, R. V. (1993) Perlecan: the multidomain heparan sulphate proteoglycan of basement membrane and extracellular matrix (editorial). Vircho. Arch. A. Pathol. Anat. Histopathol. 423, 237-242.
177. Murrel, J., Farlo, M. and Ghetti, B. et al.. (1991) A mutation of the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97-99.
178. Muruyama, K., Kawamura, Y., Asada, H., Ishiura, S. and Obata, K. (1994) Cleavage at the N-terminal site of Alzheimer amyloid b/A4 protein is essential for its secretion. Biochem. Biophys. Res. Commun. 202, 1517-1523.
179. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E. and Ikeda, K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangle in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541, 163-166.
180. Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W. and Pitas, R. E. (1994) Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro. Science 264, 850-852.
181. Nguyen, J., Baldwin, M. A., Cohen, F. E. and Prusiner, S. B. (1995) Prion protein peptides induce α-helix to β-sheet conformational transition. Biochemistry 34, 4186-4192.
182. Nicoll, J. A. R., Roberts, G. W. and Graham, D. I. (1995) Apolipoprotein E e4 allele is associated with deposition of amyloid β-protein following head injury. Nature Med. 1, 135-137.
183. Nitsch, R. M., Slack, B. E., Wurtman, R. J. and Growdon, J. G. (1992) Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
184. Nitta, A., Itoh, A., Hasegawa, T. and Nobeshima, T. (1994) β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 170, 63-66.
185. Nordstedt, C., Näslund, J., Tjernberg, L. O., Karlström, A. R., Thyberg, J. and Terenius, L. (1994) The Alzheimer Aβ peptide develops protease resistance in association with its polymerization into fibrils. J. Biol. Chem. 269, 30773-30776.
186. Oda, T., Wals, P., Osterburg, H. H., Pasinetti, G. M., Morgan, T. E., Rozovsky, I., Blainestine, W., Snyder, S. W., Holzman, F., Krafft, G. A. and Finch, C. B. (1995) Clusterin (Apo J) alters the aggregation of amyloid β-peptide (Aβ1-42) and forms slowly sedimenting Ab complexes that cause oxidative stress. Expl Neurol. 136, 22-31.
187. Oesch, B., Westaway, D., Wälchili, M., McKinley, M. P., Kent, S. B. H., Aebersold, R., Barry, R. A., Tempest, P., Teplow, D. B., Hood, L., Prusiner, S. B. and Weissmann, C. (1985) A cellular gene encodes scrapie PrP 27-30 protein. Cell 40, 735-746.
188. Olanow, C. W. (1993) A radical hypothesis for neurodegeneration. Trends Neurosci. 16, 439-444.
189. Oppenheim, R. W. (1991) Cell death during development of nervous system. Annu. Rev. Neurosci. 134, 453-501.
190. Patel, A. J. (1995) Pretreatment with a sublethal concentration o β-amyloid 25-35 potentiates neurodegeneration mediated by glutamate. Alzheimer's Res. 1, 41-44.
191. Perry, G., Cras, P., Siedlak, S. L., Tabaton, M. and Kawai, M. (1992) β-Protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. Am. J. Pathol. 140, 283-290.
192. Perry, G., Richey, P. L., Siedlak, S. L., Smith, M., Mulvihill, P., DeWitt, D. A., Barnett, J., Greenberg, B. D. and Kalaria, R. N. (1993) Immunocytochemical evidence that the β-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease. Am. J. Pathol. 143, 1586-1593.
193. Peña, L. A., Brecher, C. W. and Marshak, D. R. (1995) β-Amyloid regulates gene expression of glial trophic substance S100b in C6 glioma and primary astrocyte cultures. Mol. Brain Res, 34, 118-126.
194. Pike, C., Burdick, D., Walencewicz, A. J., Glabe, C. G. and Cotman, C. W. (1993) Neurodegeneration induced by β-amyloid peptides in vivo: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
195. Pike, C., Cummings, B. J. and Cotman, C. (1995a) Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Expl Neurol. 132, 172-179.
196. Pike, C. J., Walencewicz, A. J., Glabe, C. G. and Cotman, C. W. (1991) Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207, 367-368.
197. Pike, C. J., Cummings, B. J. and Cotman, C. W. (1992) β-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. NeuroReport 3, 369-372.
198. Pike, C. J. and Cotman, C. W. (1993) Cultured GABA-immunoreactive neurons are resistant to toxicity induced by beta-amyloid. Neuroscience 56, 269-274.
199. Pike, C. J., Walencewicz-Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G. and Cotman, C. W. (1995b) Structure-activity analyses of β-amyloid peptides: contributions of the β 5-35 region to aggregation and neurotoxicity. J. Neurochem. 64, 253-265.
200. Podinsky, M., Stephenson, D. and Frosc. M. (1992) Synthetic amyloid β-protein fails to produce specific neurotoxicity in monkey cerebral cortex. Neurobiol. Aging 13, 561-568.
201. Polvikoski, T., Sulkava, R., Haltia, M., Kainulainen, K., Vuorio, A., Verkkoniemi, A., Niinisto, L., Halonen, P. and Kontula, K. (1995) Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N. Engl. J. Med. 333, 1242-1247.
202. Ponte, P., Gonzales-De Whitt, P. and Schilling, J. (1988) A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors. Nature 331, 1080-1084.
203. Prelli, F., Castaño, E., Glenner, G. G. and Frangione, B. (1988) Differences between vascular and plaque core amyloid in Alzheimer's disease. J. Neurochem. 51, 648-651.
204. Prusiner, S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144.
205. Prusiner, S. B. (1992) Chemistry and biology of prions. Biochemistry 31, 12277-12288.
206. Raff, M. C., Barres, B. A., Burne, J. F., Coles, H. S., Ishizaki, Y. and Jacobson, M. D. (1993) Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262, 695-700.
207. Querfurth, H. W., Weisman, E. H., George-Hyslop, P. M. and Selkoe, D. (1995) βAPP mRNA transcription is increased in cultured fibroblast from the familial Alzheimer's disease - 1 family. Mol. Brain Res. 28, 319-337.
208. Ratan, R. R., Murphy, T. H. and Baraban, J. M. (1994) Oxidative stress induces apoptosis embryonic cortical neurons. J. Neurochem. 62, 376-379.
209. Reiter, R. J. (1995) Oxidative process and antioxidative defense mechanisms in the aging brain. FASEB J. 9, 526-533.
210. Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Ikeda, M., Liang, Y., Chl, H., Lin, C., Holman, K., Tsuda, T., Mar, L., Sorbi, S., Nacmias, B., Piacentini, S., Amaducci, L., Chumakov, I., Cohen, D., Lannfelt, L., Fraser, P. E., Rommens, J. M. and St George-Hyslop, P. H. (1995) Familial Alzheimer's disease in kindreds with mis-sense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
211. Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., Ward, P. and Lieberburg, I. (1992) Complement activation by β-amyloid in Alzheimer disease. Proc. Natl Acad. Sci. USA 89, 10016-10020.
212. Rogers, J., Kirby, L. C., Hempelmen, S. R., Berry, D. L., McGeer, P. L., Kasniak, A. W., Zalinski, J., Cofield, M., Mansukhani, L., Wilson, P. and Kogan, F. (1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43, 1609-1611.
213. Roher, A., ELowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zurcher-Neely, H. A., Heinrikson, R. L., Ball, M. J. and Greenberg, B. D. (1993a) Structural alteration in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268, 3072-3083.
214. Roher, A. E., Ball, M. J., Bhave, S. V. and Wakad, A. R. (1991) β-Amyloid from Alzheimer's disease brain inhibits sprouting and survival of sympathetic neurons. Biochem. Biophys. Res. Commun. 174, 572-579.
215. Roher, A. E., Lowenson, J. D., Clarke, S., Woods, A. S., Cotter, R. J., Gowing, E. and Ball, M. J. (1993b) β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 10836-10840.
216. Sambamurti, K., Shoij, J., Anderson, J. P., Papolla, M. A. and Robakis, N. (1992) Evidence of intracellular cleavage of the Alzheimer's amyloid precursor in PC12. J. Neurosci. Res. 33, 319-329.
217. Schenk, D. B., Rydel, R. E., May, P., Little, S., Panetta, J., Lieberburg, I. and Sinha, S. (1995) Therapeutic approaches related to amyloid-β peptide and Alzheimer's disease. J. Med. Chem. 32, 4141-4154.
218. Schmechel, D. E., Saunders, A. M., Strittmater, W. J., Grain, B. J., Hulette, C. M., Joo, S. H., Pericak, V. M., Goldgaber, D. and Roses, A. (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 9649-9653.
219. Schnabel, J. (1993) New Alzheimer's therapy suggested. Science 260, 1719-1720.
220. Schubert, D., Behl, C., Lesley, R., Brack, A., Dargush, R., Sagara, Y. and Kimura, H. (1995) Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl Acad. Sci. USA 92, 1989-1993.
221. Selkoe, D. (1991) The molecular pathology of Alzheimer's disease. Neuron 6, 487-498.
222. Selvaggini, C., De Gioia, L., Cantù, L., Ghibaudi, E., Diomede, L., Passerini, F., Forloni, G., Bugiani, O., Tagliavini, F. and Salmona, M. (1993) Molecular characteristics of a protease-resistant amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem. Biophys. Res. Commun. 194, 1380-1386.
223. Server, A. C. and Mobley, W. C. (1991). Neuronal cell death and the role of apoptosis, In: Apotosis; The Molecular Basis of Cell Death, Eds L. D. Tomei and F. O. Cope, pp. 263-277. Cold Spring Harbor laboratory Press: NY.
224. Seubert, P., Vigo-Pelfrey, C. and Esch, T. et al.. (1992) Isolation and quantification of soluble Alzheimer's β peptide from biological fluids. Nature 359, 325-327.
225. Shen, C. L., Scott, G. L., Merchant, F. and Murphy, R. M. (1993) Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide. Biophys. J. 65, 2383-2395.
226. Sherrington, R., Rogaev, E. I. and Liang, Y. et al.. (1995) Cloning of a gene bearing a mis-sense mutation in early-onset familial Alzheimer's disease. Nature 375, 754-760.
227. Shigenaga, M. K., Hagen, T. M. and Ames, B. N. (1994) Oxidative damage and mitochondrial decay in aging. Proc. Natl Acad. Sci. USA 91, 10771-10778.
228. Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fusion, K. S., Brigham, E. F., Wright, S., Lieberburg, I., Becker, G. W., Brems, D. N. and Ying, Li. (1994) Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol. Pharmacot. 45, 373-379.
229. Sipe, J. D. (1994) Amyloidosis. Crit. Rev. Clin. Lab. Sci. 31, 325-354.
230. Sisodia, S. S. (1992) β-Amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl Acad. Sci. USA 89, 6075-6079.
231. Smale, G., Nichols, N. R., Brady, D. R., Finch, C. E. and Horton, W. E. Jr. (1995) Evidence for apoptotic cell death in Alzheimer's disease. Expl Neurol. 133, 225-230.
232. Smith, M. A., Sayre, L. M., Monnier, V. M. and Perry, G. (1995a) Radical ageing in Alzheimer's disease. Trends Neurosci. 18, 172-176.
233. Smith, M. A., Siedlak, S. L., Richev, P. L., Mulvihill, P., Ghiso, J., Frangione, B., Tagliavini, F., Giaccone, G., Bugiani, O., Praprotnik, D., Kalaria, R. N. and Perry, G. (1995b) Tau protein directly interacts with the amyloid β-protein precursor: implications for Alzheimer's disease. Nature Med. 1, 365-369.
234. Snow, A. D., Sekiguci, R., Nochlin, D., Fraser, P., Kimata, K., Mizutani, A., Arai, M., Schreier, W. A. and Morgan, D. (1994) An important role of heparin sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain. Neuron 12, 219-234.
235. Sparkers, R. M., Simon, M., Cohn, V. H., Fournier, R. E. K., Lern, J., Klisak, I., Heinzmann, C., Blatt, C., Lucero, M., Mohandas, T., DeArmond, S. J., Westaway, D. and Prusiner, S. B. (1986) Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc. Natl Acad. Sci. USA 83, 7362-7538.
236. Spillantini, M. G., Goedert, M., Jakes, R. and Klug, A. (1990) Topographical relationship between β-amyloid and tau protein epitopes in tangle-bearing cells in Alzheimer's disease. Proc. Natl Acad. Sci. USA 87, 3952-3956.
237. Stahl, N., Boerchelt, D. R., Hsiao, K. and Prusiner, S. B. (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51, 229-240.
238. Stenstad, T., Magnus, J. H., Syse, K. and Husby, G. (1993) On the association between amyloid fibrils and glycosaminoglycans; possible interactive role of Ca2 + and amyloid P-component. Clin. Exp. Immunol. 94, 189-195.
239. Stephenson, D. T. and Clemens, J. A. (1992) In vivo effects of β-amyloid implants in rodents: lack of potentiation of damage associated with transient global forebrain ischemia. Brain Res. 586, 235-246.
240. Strittmater, W. J., Weisgraber, K. H., Goedert, M., Saunders, A. M., Huang, D., Corder, E. H., Dong, L.-M., Jakes, R., Alberts, M. J., Gilbert, J. R., Man, S.-H., Hulette, C., Einstein, G., Schmechel, D. E., Pericak-Vance, M. A. and Roses, A. (1994) Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Expl Neurol. 125, 163-171.
241. Strittmater, W. J. and Roses, A. D. (1995) Apolipoprotein E and Alzheimer disease. Proc. Natl Acad. Sci. USA 92, 4725-4727.
242. Strittmater, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L.-M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D. and Roses, A. (1993) Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 8098-8102.
243. Suzuki, N., Cheung, T. T., Cai, X. D., Odaka, A., Otvos, L. Jr., Eckman, C., Golde, T. E. and Younkin, S. G. (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor. Science 264, 1336-1340.
244. Tabaton, M., Rolleri, M., Masturzo, P., Cammarata, S., Angelini, G., Hansen, L. A., Saitoh, T., Peterson, R. B., Perry, G., Richey, P., Gambetti, P. and Bertolini, S. (1995) Apolipoprotein E e4 allele frequency is not increased in progressive supranuclear palsy. Neurology 45, 1764-1765.
245. Tagliavini, F., Giaccone, G., Frangione, B. and Bugiani, O. (1988) Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and non-demented individuals. Neurosci. Lett. 93, 191-196.
246. Tagliavini, F., Prelli, F., Verga, L., Giaccone, G., Sarma, R., Gorevic, P., Ghetti, B., Passerini, F., Ghibaudi, E., Forloni, G., Salmona, M., Bugiani, O. and Frangione, B. (1993) Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc. Natl Acad. Sci. USA 90, 9678-9682.
247. Tagliavini, F., Prelli, F., Ghiso, J., Bugiani, O., Serban, D., Prusiner, S. B., Farlow, M. R., Ghetti, B. and Frangione, B. (1991) Amyloid protein of Gerstmann-Struässler-Scheinker disease (Indiana Kindred) is an 11 kDa fragment of prion protein with an N-terminal glycine at codon 58. EMBO J. 10, 513-519.
248. Tagliavini, F., Prelli, F., Porro, M., Salmona, M., Bugiani, O. and Frangione, B. (1992) A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem. Biophys. Res. Commun. 184, 1398-1404.
249. Tagliavini, F., Prelli, F., Porro, M., Rossi, G., Giaccone, G., Farlow, M. R., Diouthy, S. R., Ghetti, B., Bugiani, O. and Frangione, B. (1994) Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 79, 695-703.
250. Takadera, T., Sakura, N., Mohri, T. and Hashimoto, T. (1993) Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention. Neurosci. Lett. 161, 41-44.
251. Takashima, A., Noguchi, K., Sato, K., Hoshino, M. and Imahori, K. (1993) Tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity. Proc. Natl Acad. Sci. USA 90, 7789-7793.
252. Tanzi, R. E., McClatchey, P. L., Lampert, E. D., Villa-Komaroff, L., Gusella, J. F. and Neve, R. L. (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331, 528-530.
253. Terry, R. D., Masliah, E. and Salmon, D. P. et al.. (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapses loss is the major correlate of cognitive impairment. Neurology 30, 572-580.
254. Terzi, E., Holzemann, G. and Seelig, J. (1994a) Reversible random coil-beta-sheet transition of the Alzheimer beta-amyloid fragment (25-35). Biochemistry 33, 1345-1350.
255. Terzi, E., Hölzemann, G. and Seelig, J. (1994b) Alzheimer β-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes. Biochemistry 33, 7434-7441.
256. 23 residue affects the aggregation properties of Alzheimer amyloid β protein analogs. J. Biol. Chem. 269, 10205-10208.
257. Tomiyama, T., Asano, S., Suwa, Y., Morita, T., Kataoka, K.-I., Mori, H. and Endo, N. (1994b) Rifampicin prevents the aggregation and neurotoxicity of amyloid β protein in vitro. Biochem. Biophys. Res. Commun. 204, 76-83.
258. Tomiyama, T., Shoji, A., Kataoka, K. I., Suwa, Y., Asano, S., Kaneko, H. and Endo, N. (1996) Inhibition of amyloid β protein aggregation and neurotoxicity by rinfampicin. J. Biol. Chem. 271, 6839-6844.
259. Tomlinson, B. E. (1992). Ageing and dementias. In Greenfield's Neuropathology, Eds J. Hume-Adams and L. V. Duchenne, pp. 1283-1410. Edward Arnold: London.
260. Urbanyi, Z., Lakics, V. and Erdo, S. L. (1994) Serum amyloid P component-induced cell death in primary cultures of rat cerebral cortex. Eur. J. Pharmacol. 270, 375-378.
261. Virchow, R. (1851) Bau und Zusammensetzung der amylacea des menschen. Verh. Phys. Med. Ges. Wurzburg. 2, 51-54.
262. Vitek, P. M., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K. and Cerami, A. (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 91, 4766-4770.
263. Volterra, A., Trotti, D., Tromba, C., Floridi, S. and Racagni, G. (1994) Glutamate uptake by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14, 2924-2932.
264. Wang, L., Miura, M., Bergeron, L., Zhu, H. and Yuan, J. (1994) Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78, 739-750.
265. Watanabe, R. and Duchen, L. W. (1993) Cerebral amyloid in human prion disease. Neuropathol. Appl. Neurobiol. 19, 253-260.
266. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62, 372-375.
267. Weissmann, C. (1991) The prion's progress. Nature 349, 569-571.
268. Westaway, D., DeArmond, S. J., Cayetano-Canias, J., Groth, D., Foster, D., Yang, S.-L., Torchia, M., Carlson, G. A. and Prusiner, S. B. (1994) Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild prion protein. Cell 76, 117-129.
269. Whitson, J. S., Selkoe, D. and Cotman, C. W. (1989) Amyloid β protein enhances the survival of hippocampal neurons in vitro. Science 243, 1488-1490.
270. Whitson, J. S., Glabe, C. G., Shintani, E., Abcar, A. and Cotman, C. W. (1990) β-Amyloid protein promotes neuritic branching in hippocampal cultures. Neurosci. Lett. 110, 319-324.
271. Wisniewski, K. E., Wisniewski, H. M. and Wen, G. Y. (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17, 278-282.
272. Wisniewski, T., Ghiso, J. and Frangione, B. (1991) Peptide homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem. Biophys. Res. Commun. 179, 1247-1254.
273. Wisniewski, T., Castano, E. M., Golabek, A., Vogel, T. and Frangione, B. (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145, 1030-1035.
274. Wisniewski, T., Lalowski, M., Golabek, A. and Vogel, T. (1995a) Is Alzheimer's disease an apolipoprotein E amyloidosis?. The Lancet 345, 956-958.
275. Wisniewski, T., Patha, J. A., Ghiso, J. and Frangione, B. (1995b) S182 protein in Alzheimer's disease neuritic plaque. The Lancet 346, 1366.
276. Wood, J. A., Wood, P. L., Ryan, R., Graff Radford, N. R., Pilapil, C., Robitaille, Y. and Quirion, R. (1993) Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res. 629, 245-252.
277. Wood, S. J., Wetzel, R., Martin, J. D. and Hurle, M. R. (1995) Prolines and amyloidogenicity in fragments of the Alzheimer's peptide β/A4. Biochemistry 34, 724-730.
278. Woods, A. G., Cribbs, D. H., Whittemore, E. R. and Cotman, C. W. (1995) Heparin sulfate and chondroitin sulfate glycosaminoglycan attenuate β-amyloid (25-35) induced neurodegeneration in cultured hippocampal. Brain Res. 697, 53-62.
279. Yang, A. J., Knauer, M., Burdick, D. A. and Glabe, C. (1995) Intracellular Aβ1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. J. Biol. Chem. 270, 14786-14792.
280. Yankner, B. S., Dawes, R. L., Fisher, S., Villa-Kamaroff, L., Oster-Granite, M. L. and Neve, R. (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245, 417-420.
281. Yankner, B. S., Duffy, L. K. and Kirshner, D. A. (1990) Neurotrophic and neurotoxic effects of β-amyloid protein: reversal by tachykinin neuropeptides. Science 250, 279-282.
282. Ying Li, W., Czilli, D. L. and Simmons, L. K. (1995) Neuronal membrane conductance activated by amyloid β peptide: importance of peptide conformation. Brain Res, 682, 207-211.
283. Yoshimoto, M., Iwai, A., Kang, D., Otero, D. A. C., Xia, Y. and Saitoh, T. (1995) NACP, the precursor protein of the non-amyloid β/A4 protein (Aβ) component of Alzheimer disease amyloid, binds Aβ and stimulates Aβ aggregation. Proc. Natl Acad. Sci. USA 92, 9141-9145.
284. Zagorski, M. G. and Barrow, C. J. (1992) NMR studies of amyloid β peptides: proton assignments, secondary structure, and mechanism of an α-helix and β sheet conversion for homologous 28-residue. N-terminal fragment. Biochemistry 31, 5621-5631.
285. Zhang, Z., Drzewiecki, G. J., Horn, J. T., May, P. C. and Hyslop, P. A. (1994) Human cortical neuronal (HCN) cell lines: a model for amyloid β neurotoxicity. Neurosci. Lett. 177, 162-164.